These data indicated that metronomic Celecoxib inhibited basal as well as PGE2-stimulated cellular invasion, implicating the involvement of COX-2/PGE2-independent mechanisms in the suppression of invasive properties of HCC cells. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.